Hado Therapeutics Ltd
12240559
Healthy
- Negative net worth (-10)
Details
Compliance
Last accounts
31/03/2025
micro entity
Next accounts due
31/12/2026
Confirmation statement
Last: 05/06/2026
Due 19/06/2027
Industry
Officers
director · Since 01/02/2020
LECTURER IN THERAPEUTICS
BRITISH · UNITED KINGDOM · Age 49
Also on 1 other board
director · Since 01/02/2020
SOFTWARE PROFESSIONAL
AMERICAN · UNITED STATES · Age 59
Persons with Significant Control
Dr Vijay Kumar Pabbathi
British · United Kingdom · Age 62
Institute Of Cancer Therapeutics, University Of Bradford, Bradford, BD7 1DP
Notified 03/10/2019
CompanyRankvs 58096+ SIC 74909 peers26
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
-£18k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£16k
Working capital
Current Assets
£340
Current Liabilities
£17k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 0.02 | -£3k |
| 2025 | 0.06 | -£5k |
| 2024 | 0.08 | -£7k |
| 2023 | 0.71 | — |
Derived from filed accounts. Not audited figures.